- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/24 - 1,2,4-ThiadiazinesHydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
Patent holdings for IPC class C07D 285/24
Total number of patents in this class: 44
10-year publication summary
3
|
3
|
1
|
3
|
1
|
7
|
2
|
3
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Essentialis, Inc. | 23 |
6 |
Mayo Foundation for Medical Education and Research | 3135 |
4 |
Nxera Pharma UK Limited | 120 |
4 |
University of Florida Research Foundation, Inc. | 3971 |
2 |
Anadys Pharmaceuticals, Inc. | 30 |
2 |
Regents of the University of Minnesota | 2687 |
2 |
Soochow University | 1725 |
2 |
Qlaris Bio, Inc. | 11 |
2 |
Alla Chem, LLC | 56 |
1 |
Ardea Biosciences, Inc. | 76 |
1 |
Cellixbio Private Limited | 167 |
1 |
CorMedix Inc. | 56 |
1 |
Cornell University | 3233 |
1 |
Gamptec GmbH | 2 |
1 |
Heptares Therapeutics Limited | 118 |
1 |
High Point Pharmaceuticals, LLC | 32 |
1 |
Icahn School of Medicine at Mount Sinai | 913 |
1 |
Les Laboratoires Servier | 586 |
1 |
Senomyx, Inc. | 80 |
1 |
Takeda San Diego, Inc. | 18 |
1 |
Other owners | 8 |